Insider filing · MAZE
Catherine A. Sohn
Director
profile →
Maze Therapeutics, Inc.
MAZE · Healthcare · 36 filings in 24 months
ticker →
Catherine A. Sohn sold $1.1M of Maze Therapeutics (MAZE)
Executed Jan 7, disclosed Jan 8, 1 day later.
Value, as filed
$1.1M
26,920 sh × $39.11
Executed
Jan 7
the trade date, as filed
Disclosed
Jan 8
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CSCatherine A. Sohn (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $1.1M of MAZE (26,920 sh × $39.11, as filed), executed Jan 7.
The name
MAZEHealthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→